Evidence map›Paper›PMID 37979958›Full record

ArticleAnnals of the rheumatic diseases2024

OA susceptibility in mice is partially mediated by the gut microbiome, is transferrable via microbiome transplantation and is associated with immunophenotype changes.

Emmaline Prinz, Leoni Schlupp, Gabby Dyson, Montana Barrett, Aleksander Szymczak, Cassandra Velasco, Vladislav Izda, Christopher M Dunn, Matlock A Jeffries

Open access · greenAbstract read
In one paragraph

Article in Annals of the rheumatic diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. The gut-joint axis in osteoarthritis.Nature reviews. Rheumatology · 2026
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Gut and Joint Microbiomes: Implications in Osteoarthritis.Rheumatic diseases clinics of North America · 2025
    Review
  14. Osteoarthritis.Nature reviews. Disease primers · 2025
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Emmaline PrinzArthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Leoni SchluppArthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Gabby DysonArthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Montana BarrettArthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Aleksander SzymczakArthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Cassandra VelascoDivision of Rheumatology, Immunology, and Allergy, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Vladislav IzdaArthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Christopher M DunnArthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Matlock A JeffriesArthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA matlock-jeffries@omrf.org.ORCID http://orcid.org/0000-0001-9516-4312
Oklahoma Medical Research Foundation · USENT and Allergy · US

Funding

Visualizing insulin actions on neuronal metabolism and function using fluorescent biosensorsP20GM125528 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Archana Unnikrishnan · 2019 to 2026
$17.8M
Peripheral blood mononuclear cell epigenetic associations in and biomarkers for knee osteoarthritis development and progression.R01AR076440 · NIAMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BHUTANI, NIDHI, JEFFRIES, MATLOCK · 2020 to 2025
$3.6M
An integrative study of circulating leukocyte composition, epigenetic patterns, and functional consequences in knee osteoarthritis.K08AR070891 · NIAMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI JEFFRIES, MATLOCK · 2017 to 2021
$862k
Intraarticular microbial DNA as a novel mediator of osteoarthritisR61AR078075 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JEFFRIES, MATLOCK · 2020 to 2021
$861k
Intraarticular microbial DNA as a novel mediator of osteoarthritisR33AR078075 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JEFFRIES, MATLOCK · 2022 to 2022
$437k
Cartilage Microbial Products as Novel Drivers of Knee Osteoarthritis Epigenetic DysregulationI01CX002494 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI Matlock Jeffries · 2023 to 2026
–
CSRD VA I01 CX002494NIAMS NIH HHS K08 AR070891NIAMS NIH HHS R01 AR076440NIAMS NIH HHS R33 AR078075NIAMS NIH HHS R61 AR078075NIGMS NIH HHS P20 GM125528
6 · The paper itself

Abstract

objectivesThe Murphy Roths Large (MRL)/MpJ 'superhealer' mouse strain is protected from post-traumatic osteoarthritis (OA), although no studies have evaluated the microbiome in the context of this protection. This study characterised microbiome differences between MRL and wild-type mice, evaluated microbiome transplantation and OA and investigated microbiome-associated immunophenotypes.

methodsCecal material from mixed sex C57BL6/J (B6) or female MRL/MpJ (MRL) was transplanted into B6 and MRL mice, then OA was induced by disruption of the medial meniscus surgery (DMM). In other experiments, transplantation was performed after DMM and transplantation was performed into germ-free mice. Transplanted mice were bred through F2. OARSI, synovitis and osteophyte scores were determined blindly 8 weeks after DMM. 16S microbiome sequencing was performed and metagenomic function was imputed. Immunophenotypes were determined using mass cytometry.

resultsMRL-into-B6 transplant prior to DMM showed reduced OA histopathology (OARSI score 70% lower transplant vs B6 control), synovitis (60% reduction) and osteophyte scores (30% reduction) 8 weeks after DMM. When performed 48 hours after DMM, MRL-into-B6 transplant improved OA outcomes but not when performed 1-2 weeks after DMM. Protection was seen in F1 (60% reduction) and F2 progeny (30% reduction). Several cecal microbiome clades were correlated with either better (eg,

conclusionThe gut microbiome is responsible in part for OA protection in MRL mice and is transferrable by microbiome transplantation. Transplantation induces resting systemic immunophenotyping changes that correlate with OA protection.

Indexed as

Cartilage, ArticularGastrointestinal MicrobiomeMicrobiotaOsteophyteSynovitisAnimalsDisease Models, AnimalFemaleImmunophenotypingMiceMice, Inbred C57BLInflammationOsteoarthritisOsteoarthritis, Knee

Identifiers

PMID37979958
PMCPMC10922159
OpenAlexW4388789413

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.